A clinical perspective of obesity, metabolic syndrome and cardiovascular disease
Open accessThe DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.
Abstract
The metabolic syndrome is a condition characterized by a special constellation of reversible major risk factors for cardiovascular disease and type 2 diabetes. The main, diagnostic, components are reduced HDL-cholesterol, raised triglycerides, blood pressure and fasting plasma glucose, all of which are related to weight gain, specifically intra-abdominal/ectopic fat accumulation and a large waist circumference. Using internationally adopted arbitrary cut-off values for waist circumference, having metabolic syndrome doubles the risk of cardiovascular disease, but offers an effective treatment approach through weight management. Metabolic syndrome now affects 30–40% of people by age 65, driven mainly by adult weight gain, and by a genetic or epigenetic predisposition to intra-abdominal/ectopic fat accumulation related to poor intra-uterine growth. Metabolic syndrome is also promoted by a lack of subcutaneous adipose tissue, low skeletal muscle mass and anti-retroviral drugs. Reducing weight by 5–10%, by diet and exercise, with or without, anti-obesity drugs, substantially lowers all metabolic syndrome components, and risk of type 2 diabetes and cardiovascular disease. Other cardiovascular disease risk factors such as smoking should be corrected as a priority. Anti-diabetic agents which improve insulin resistance and reduce blood pressure, lipids and weight should be preferred for diabetic patients with metabolic syndrome. Bariatric surgery offers an alternative treatment for those with BMI ≥ 40 or 35–40 kg/m 2 with other significant co-morbidity. The prevalence of the metabolic syndrome and cardiovascular disease is expected to rise along with the global obesity epidemic: greater emphasis should be given to effective early weight-management to reduce risk in pre-symptomatic individuals with large waists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other health implications include a reduced quality of life (physical, mental, and social wellbeing), increased loss of income due to work absenteeism [128-130], and an increased risk of obesityassociated disease [127,131].”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“Modest lifestyle interventions are also effective in reducing the risk of developing diabetes in individuals with glucose intolerance.(68,69) The composition of macronutrients has been shown to similarly benefit risk reduction.”
BackgroundDetection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“Modest lifestyle interventions are also effective in reducing the risk of developing diabetes in individuals with glucose intolerance.(68,69) The composition of macronutrients has been shown to similarly benefit risk reduction.”
Background‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
Hills, A. P., Byrne, N. M., Lindstrom, R., & Hill, J. O. (2013) · Obesity Facts · doi:10.1159/000345030 · Cited by 9,493
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
Faith, M. S., Carnell, S., & Kral, T. V. E. (2013) · Human Heredity · doi:10.1159/000353879 · Cited by 7,601
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698 · cited 1×
“By the age of 70, the prevalence of metabolic syndrome rose to 42% among American men and women.(62) It is likely that the prevalence of metabolic syndrome will continue to rise in the future given the persistently rising trends in obesity, especially among young people.”
BackgroundAlberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597 · cited 3×
“The IDF proposed a simpler set of criteria requiring a large waist circumference but set at a slightly lower level than that of NCEP, plus any two of the other components.(6) The IDF criteria were produced to incorporate prevention of diabetes, as well as CVD, thus the lower cut-off ‘action levels’ of waist circumfere…”
BackgroundMethodInfluentialLippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R. B., Elliott, K. S., Lango, H., Rayner, N. W., et al. (2007) · Science · doi:10.1126/science.1141634 · Cited by 4,531
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896 · cited 1×
“(GLP-1R) agonists directly activate GLP-1R expressed in the pancreatic b-cells, leading to enhanced insulin synthesis and secretion in the presence of elevated plasma glucose.(77) GLP-1R agonists have also been shown to suppress the secretion of glucagon.”
BackgroundMechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Congenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814 · cited 3×
“Anti-obesity drugs or other agents such as PPARg agonists and GLP-1R agonists may also be considered as primary prevention of metabolic syndrome and CVD.”
BackgroundThe fetal and infant origins of adult disease.
Barker, D. J. (1990) · BMJ · doi:10.1136/bmj.301.6761.1111 · Cited by 2,768
Swinburn, B., Egger, G., & Raza, F. (1999) · Preventive Medicine · doi:10.1006/pmed.1999.0585 · Cited by 2,267 · cited 1×
“The metabolic syndrome is strongly linked to a lifestyle characterized by an easy access to unlimited supply of high caloric, low nutrient-dense, foods and physical inactivity.(20,21) This exposure is most potent during early period of life resulting in childhood obesity which is a major risk for metabolic syndrome in…”
BackgroundPathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085 · cited 2×
“Insulin resistance is closely related to impaired glucose tolerance, diabetes and risk of CHD.(37)”
BackgroundWaist circumference as a measure for indicating need for weight management
Lean, M. E. J., Han, T. S., & Morrison, C. E. (1995) · BMJ · doi:10.1136/bmj.311.6998.158 · Cited by 1,869 · cited 1×
“Lean et al.(4) 2 Journal of the Royal Society of Medicine Cardiovascular Disease 5(0)”
BackgroundSelf-citationMalik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L’Italien, G. J., Pio, J. R., & Williams, G. R. (2004) · Circulation · doi:10.1161/01.cir.0000140677.20606.0e · Cited by 1,848
Scuteri, A., Sanna, S., Chen, W.-M., Uda, M., Albai, G., Strait, J., Najjar, S., Nagaraja, R., Orrú, M., Usala, G., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030115 · Cited by 1,724 · cited 1×
“The first single nucleotide polymorphism (SNP) associated with increased BMI was mapped to a gene now known as FTO (fat mass and obesity associated) in 2007.(26,27) FTO gene acts by regulating appetite and energy expenditure.”
BackgroundMedical Consequences of Obesity
Bray, G. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0535 · Cited by 1,538 · cited 4×
“Anti-obesity drugs or other agents such as PPARg agonists and GLP-1R agonists may also be considered as primary prevention of metabolic syndrome and CVD.”
BackgroundInfluentialThe deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
Kaplan, N. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.7.1514 · Cited by 1,516 · cited 3×
“Many hypertensive individuals have glucose intolerance and hyperinsulinaemia.(36) However, this association is probably not causally linked since controlling hypertension neither improves glucose intolerance or hyperinsulinaemia(38) and hypertension is not observed in patients with insulinoma.”
BackgroundInfluentialEnvironmental Influences on Eating and Physical Activity
French, S. A., Story, M., & Jeffery, R. W. (2001) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.22.1.309 · Cited by 1,476 · cited 1×
“The metabolic syndrome is strongly linked to a lifestyle characterized by an easy access to unlimited supply of high caloric, low nutrient-dense, foods and physical inactivity.(20,21) This exposure is most potent during early period of life resulting in childhood obesity which is a major risk for metabolic syndrome in…”
BackgroundBody mass index as a measure of body fatness: age- and sex-specific prediction formulas
Deurenberg, P., Weststrate, J. A., & Seidell, J. C. (1991) · British Journal of Nutrition · doi:10.1079/bjn19910073 · Cited by 1,358 · cited 1×
“It is important to point out that BMI is not a strong predictor of body fat: in most studies which have measured estimated total body fat by a reference method (underwater weighing, deuterium oxide dilution dispersal and magnetic resonance imaging), the amount of variance (R(2)) in body fat explained by BMI is about 7…”
BackgroundMetabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis
Galassi, A., Reynolds, K., & He, J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.031 · Cited by 1,207
Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
Self-citation"Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes.
Björntorp, P. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.493 · Cited by 1,127 · cited 1×
“It is thought that the large amounts of FFAs released by the metabolically active intra-abdominal fat mass, via the portal system into the liver, may interfere with hepatic insulin clearance.(44) Intra-abdominal fat which has its origin as brown adipose tissue (mainly omental and retroperitoneal), exhibits greater mit…”
BackgroundFetal and infant origins of adult disease
Barker, D. J. P. (2001) · Monatsschrift Kinderheilkunde · doi:10.1007/s001120170002 · Cited by 1,042 · cited 1×
“Using the thrifty and programming hypotheses, Barker suggested that poor nutrition in utero and early life has an adverse effect on the structure and function of vital organs.(53) Since the endocrine and cardiovascular systems develop late in the foetus, they are more severely affected by undernutrition in the later t…”
MethodGreenway, F. L., Fujioka, K., Plodkowski, R. A., Mudaliar, S., Guttadauria, M., Erickson, J., Kim, D. D., & Dunayevich, E. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60888-4 · Cited by 1,036 · cited 1×
“1%).(83) In general, weight loss through diet and lifestyle plus anti-obesity drugs results in improvement in all the cardiovascular risk factors of metabolic syndrome.”
BackgroundDavidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947
British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary
Williams, B., Poulter, N. R., Brown, M. J., Davis, M., McInnes, G. T., Potter, J. F., Sever, P. S., & Thom, S. M. (2004) · BMJ · doi:10.1136/bmj.328.7440.634 · Cited by 848 · cited 2×
“CVD risk based on Joint British Societies’ guideline or equivalent.(67) Han and Lean 7”
MethodPrevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Targher, G., Alberiche, M., Bonadonna, R. C., & Muggeo, M. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1643 · Cited by 837 · cited 1×
“Some of the links between components of the metabolic syndrome relate to insulin resistance, although about a third of patients with the metabolic syndrome have normal insulin sensitivity.(35) Insulin resistance is characterized by a high plasma insulin concentration that fails to suppress plasma glucose normally.”
BackgroundPPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
The link between abdominal obesity, metabolic syndrome and cardiovascular disease
Ritchie, S. A., & Connell, J. M. C. (2007) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.07.005 · Cited by 726 · cited 1×
“plasminogen activator inhibitor-1).(1) Reaven(2) was the first to draw attention to this clustering of metabolic abnormalities, particularly in overweight individuals.”
BackgroundThe bigger picture of FTO—the first GWAS-identified obesity gene
Loos, R. J. F., & Yeo, G. S. H. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.227 · Cited by 723 · cited 1×
“Over 40 genetic variants since have been identified to associate with BMI, fat distribution or risk of obesity and metabolic syndrome.(28) Although only a small proportion of variance in BMI (<2%) is observed to be attributable to common allelic variants, these risk alleles make substantial contribution to obesity in…”
BackgroundSjöström, C. D., Lissner, L., Wedel, H., & Sjöström, L. (1999) · Obesity Research · doi:10.1002/j.1550-8528.1999.tb00436.x · Cited by 693 · cited 1×
“On the other hand, obesity contributes to hypertension and hyperinsulinaemia, while weight reduction usually improves both of these disorders.(40) Insulin resistance and hyperinsulinaemia could directly cause hypertension via an increase in catecholamine activity independent of plasma glucose concentration.”
Backgroundvan Vliet‐Ostaptchouk, J. V., Nuotio, M.-L., Slagter, S. N., Doiron, D., Fischer, K., Foco, L., Gaye, A., Gögele, M., Heier, M., Hiekkalinna, T., et al. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-9 · Cited by 685 · cited 1×
“The prevalence of metabolic syndrome is estimated to be between 10 and 30%, increasing sharply in older age-groups in most European countries.(60) Data from the National Health and Nutrition Examination Survey showed that the prevalence of metabolic syndrome in the United States was 28% in the 1988– 1994 survey and ha…”
BackgroundLaaksonen, D. E., Lakka, H.-M., Salonen, J. T., Niskanen, L. K., Rauramaa, R., & Lakka, T. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1612 · Cited by 657 · cited 1×
“Physical activity has benefits above its role in weight control by reducing the risk of developing metabolic syndrome.(72) In individuals with type 2 diabetes whose risk for CVD is accentuated, more intensive risk factor management is warranted.”
BackgroundMetabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
Dekker, J. M., Girman, C., Rhodes, T., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · Circulation · doi:10.1161/circulationaha.104.516948 · Cited by 632
van Vliet‐Ostaptchouk, J. V., Nuotio, M.-L., Slagter, S. N., Doiron, D., Fischer, K., Foco, L., Gaye, A., Gögele, M., Heier, M., Hiekkalinna, T., et al. (2014) · NORA - Norwegian Open Research Archives · Cited by 620
“Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries
Cannon, R. O., & Epstein, S. E. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91180-0 · Cited by 580
Mozumdar, A., & Liguori, G. (2011) · Diabetes Care · doi:10.2337/dc10-0879 · Cited by 551 · cited 1×
“Data from the National Health and Nutrition Examination Survey showed that the prevalence of metabolic syndrome in the United States was 28% in the 1988– 1994 survey and had risen to 34% in the 1999–2004 survey.(61) By the age of 70, the prevalence of metabolic syndrome rose to 42% among American men and women.”
BackgroundBrancati, F. L., Kao, W. H. L., Folsom, A. R., Watson, R. L., & Szklo, M. (2000) · JAMA · doi:10.1001/jama.283.17.2253 · Cited by 501
Stahl, S. M., Pradko, J., Haight, B. R., Modell, J. G., Rockett, C. B., & Learned-Coughlin, S. (2004) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v06n0403 · Cited by 495
Muscle fiber type is associated with obesity and weight loss
Tanner, C. J., Barakat, H. A., Dohm, G. L., Pories, W. J., MacDonald, K. G., Cunningham, P. R. G., Swanson, M. S., & Houmard, J. A. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00416.2001 · Cited by 493 · cited 1×
“has suggested that the metabolic sensitivity to adiposity was greater in South Asian children than white European children, while another study has shown that African American women had increased proportions of the less oxidative and more insulin resistant type IIB muscle fibres than white women.(58) These findings ar…”
ResultPredicting body composition by densitometry from simple anthropometric measurements
Lean, M., Han, T., & Deurenberg, P. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.1.4 · Cited by 370 · cited 1×
“It is important to point out that BMI is not a strong predictor of body fat: in most studies which have measured estimated total body fat by a reference method (underwater weighing, deuterium oxide dilution dispersal and magnetic resonance imaging), the amount of variance (R(2)) in body fat explained by BMI is about 7…”
BackgroundSelf-citationMattar, S. G., Velcu, L. M., Rabinovitz, M., Demetris, A. J., Krasinskas, A. M., Barinas-Mitchell, E., Eid, G. M., Ramanathan, R., Taylor, D. S., & Schauer, P. R. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000179652.07502.3f · Cited by 341
Matikainen, N., Mänttäri, S., Schweizer, A., Ulvestad, A., Mills, D., Dunning, B. E., Foley, J. E., & Taskinen, M.-R. (2006) · Diabetologia · doi:10.1007/s00125-006-0340-2 · Cited by 336
Insulin Resistance, Glucose Intolerance and Hyperinsulinemia in Patients with Hypertension
Swislocki, A. L. M., Hoffman, B. B., & Reaven, G. M. (1989) · American Journal of Hypertension · doi:10.1093/ajh/2.6.419 · Cited by 316
Kelly, I. E., Han, T. S., Walsh, K., & Lean, M. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.288 · Cited by 315
Self-citationUpdate on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Johnson, B. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.005 · Cited by 264 · cited 1×
“Naltrexone, used as treatment for alcohol dependence, is an opioid receptor antagonist which reduces cravings by inhibiting the action of b-endorphins on dopaminergic reward pathways.(82) Treatment with the combination of sustained-release naltrexone (32mg/day) and bupropion (360mg/day) over 56 weeks has been shown to…”
BackgroundVanhala, M., Vanhala, P., Kumpusalo, E., Halonen, P., & Takala, J. (1998) · BMJ · doi:10.1136/bmj.317.7154.319 · Cited by 263 · cited 1×
“This exposure is most potent during early period of life resulting in childhood obesity which is a major risk for metabolic syndrome in adults.(22) Psychosocial stress has also been suggested to contribute, with most metabolic components are more prevalent in socioeconomically deprived populations.”
BackgroundNaude, C. E., Schoonees, A., Senekal, M., Young, T., Garner, P., & Volmink, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100652 · Cited by 252 · cited 1×
“A recent meta-analysis of 19 randomized controlled trial (n1⁄4 3209) of a minimum of 12 weeks follow-up has shown no differences in metabolic outcomes from weight loss with low-carbohydrate compared with higher-carbohydrate/balanced diets for type 2 diabetes or non-diabetic subjects.(70) Similar findings were observed…”
ResultFujioka, K., Seaton, T. B., Rowe, E., Jelinek, C. A., Raskin, P., Lebovitz, H. E., Weinstein, S. P., & Group, T. S. C. S. (2000) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00081.x · Cited by 244
Metabolic Changes in Persons After Spinal Cord Injury
Bauman, W. A., & Spungen, A. M. (2000) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/s1047-9651(18)30150-5 · Cited by 228 · cited 1×
“capacity) is associated with increased central fat distribution and metabolic disorders.(49) Observations of high incidence of the metabolic syndrome in individuals with partial lipodystrophy or those with spinal cord injury have highlighted the important roles of subcutaneous adipose tissue and skeletal muscle in the…”
BackgroundSmoyer-Tomic, K. E., Spence, J. C., Raine, K. D., Amrhein, C., Cameron, N., Yasenovskiy, V., Cutumisu, N., Hemphill, E., & Healy, J. (2008) · Health & Place · doi:10.1016/j.healthplace.2007.12.001 · Cited by 221 · cited 1×
“Psychosocial stress has also been suggested to contribute, with most metabolic components are more prevalent in socioeconomically deprived populations.(23) Not all individuals go on to develop the metabolic syndrome because of the high individual variation and genetic/epigenetic factors for both the components of the…”
BackgroundBrown adipose tissue uncoupling protein content in human infants, children and adults
Lean, M. E. J., James, W. P. T., Jennings, G., & Trayhurn, P. (1986) · Clinical Science · doi:10.1042/cs0710291 · Cited by 213 · cited 1×
“Intra-abdominal fat which has its origin as brown adipose tissue (mainly omental and retroperitoneal), exhibits greater mitochondrial density and rates of lipolysis and glycolysis than the subcutaneous white adipose tissue.(45) Intraabdominal fat appears to be primarily involved in high-turnover distribution of FFAs t…”
BackgroundSelf-citationPPAR gamma and human metabolic disease
Chatterjee, K. (2006) · 8th European Congress of Endocrinology incorporating the British Endocrine Societies · Cited by 209
Seidell, J. C., Han, T. S., Feskens, E. J. M., & Lean, M. E. J. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00235.x · Cited by 208 · cited 1×
“Waist circumference predicts body fat similarly,(15) but is a somewhat better guide to cardiometabolic disease risks because it identifies people with relatively low BMI but with increased intra-abdominal fat accumulation.(16) A more rational approach to obesity would use the published, validated, equations to estimat…”
BackgroundSelf-citationImpact of weight loss on the metabolic syndrome
Case, C. C., Jones, P. H., Nelson, K., O'Brian Smith, E., & Ballantyne, C. M. (2002) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00236.x · Cited by 201
Han, T. S., Williams, K., Sattar, N., Hunt, K. J., Lean, M. E. J., & Haffner, S. M. (2002) · Obesity Research · doi:10.1038/oby.2002.126 · Cited by 190 · cited 1×
“Increased intra-abdominal fat accumulation, indicated by a large waist circumference, may have a direct intermediary role in the development of the metabolic syndrome.(43) It is thought that the large amounts of FFAs released by the metabolically active intra-abdominal fat mass, via the portal system into the liver, m…”
BackgroundSelf-citationBatsis, J. A., Romero-Corral, A., Collazo-Clavell, M. L., Sarr, M. G., Somers, V. K., & Lopez-Jimenez, F. (2008) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60766-0 · Cited by 179
Rector, R. S., Warner, S. O., Liu, Y., Hinton, P. S., Sun, G. Y., Cox, R. H., Stump, C. S., Laughlin, M. H., Dellsperger, K. C., & Thomas, T. R. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00116.2007 · Cited by 147
A supersized list of obesity genes
Hofker, M. H., & Wijmenga, C. (2009) · Nature Genetics · doi:10.1038/ng0209-139 · Cited by 139 · cited 1×
“Although only a small proportion of variance in BMI (<2%) is observed to be attributable to common allelic variants, these risk alleles make substantial contribution to obesity in a polygenic manner such that people who carry a higher number of variants (more than 10) will likely to gain extra weight than those who ca…”
BackgroundTorp-Pedersen, C., Caterson, I., Coutinho, W., Finer, N., Van Gaal, L., Maggioni, A., Sharma, A., Brisco, W., Deaton, R., Shepherd, G., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm217 · Cited by 132 · cited 3×
“Anti-obesity drugs or other agents such as PPARg agonists and GLP-1R agonists may also be considered as primary prevention of metabolic syndrome and CVD.”
BackgroundBoschmann, M., Engeli, S., Dobberstein, K., Budziarek, P., Strauss, A., Boehnke, J., Sweep, F. C. G. J., Luft, F. C., He, Y., Foley, J. E., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1400 · Cited by 116 · cited 2×
“A few studies of small samples and short term duration of treatment with DPP-4 inhibitors have shown conflicting results79 while Boschmann et al.80 found no changes in a number of risk factors.”
ResultLaparoscopic Gastric Bypass beyond Age 60
Sosa, J. L., Pombo, H., Pallavicini, H., & Ruiz-Rodriguez, M. (2004) · Obesity Surgery · doi:10.1381/0960892042583833 · Cited by 114 · cited 1×
“It is important therefore optimized non-surgical approaches should be offered readily for obese individuals.(88) If the aim is a more modest maintained weight loss of 15 kg (adequate to reverse type 2 diabetes) is the target, then low-energy liquid diet methods may be cheaper and safer than surgical option.”
BackgroundHall, L. M. L., Moran, C. N., Milne, G. R., Wilson, J., MacFarlane, N. G., Forouhi, N. G., Hariharan, N., Salt, I. P., Sattar, N., & Gill, J. M. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014197 · Cited by 106 · cited 1×
“These findings are in line with another small study of 20 British South Asians and 20 white British men of similar BMI, showing South Asian men had reduced insulin sensitivity, exercise capacity and skeletal muscle expression of key insulin signalling proteins.(59)”
ResultWhat is the risk of coronary heart disease in South Asians? A review of UK research
Bhopal, R. (2000) · Journal of Public Health · doi:10.1093/pubmed/22.3.375 · Cited by 103
Treatment and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Walker, B. R., Arlt, W., & Ross, R. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.239 · Cited by 102 · cited 1×
“Lifelong exposure to glucocorticoids, such as in patients with congenital adrenal hyperplasia to control hyperandrogenism is linked to excess risk of obesity and metabolic disorders.(50,51) In cancer survivors, who are known to have increased risk of CVD, excess rates of obesity and metabolic disorders have been obser…”
BackgroundSelf-citationGenetics and the metabolic syndrome.
Bouchard, C. (1995) · PubMed · Cited by 95
Christensen, P., Bliddal, H., Riecke, B. F., Leeds, A., Astrup, A. V., & Christensen, R. (2011) · Clinical Obesity · doi:10.1111/j.1758-8111.2011.00006.x · Cited by 88
Lean, M., Brosnahan, N., McLoone, P., McCombie, L., Higgs, A. B., Ross, H., Mackenzie, M., Grieve, E., Finer, N., Reckless, J., et al. (2013) · British Journal of General Practice · doi:10.3399/bjgp13x663073 · Cited by 87
Self-citationLean, M., Han, T. S., Bush, H., Anderson, A. S., Bradby, H., & Williams, R. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801823 · Cited by 80 · cited 1×
“There is evidence that increased central body fat distribution, commonly observed in migrant South Asians compared with general white British, diminished in the next generation of British-born South Asians, at least in females.(54) However, the persistent greater risk of diabetes and hypertension in African Americans(…”
BackgroundSelf-citationNightingale, C. M., Rudnicka, A. R., Owen, C. G., Wells, J. C. K., Sattar, N., Cook, D. G., & Whincup, P. H. (2013) · Diabetes Care · doi:10.2337/dc12-1726 · Cited by 76 · cited 2×
“A study by Nightingale et al.57 has suggested that the metabolic sensitivity to adiposity was greater in South Asian children than white European children, while another study has shown that African American women had increased proportions of the less oxidative and more insulin resistant type IIB muscle fibres than wh…”
BackgroundAlgindan, Y., Hankey, C., Govan, L., Gallagher, D., Heymsfield, S. B., & Lean, M. E. J. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.070466 · Cited by 76
Self-citationGlucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Stimson, R. H., Rees, D. A., Krone, N., Willis, D. S., Conway, G. S., Arlt, W., Walker, B. R., Ross, R. J., & (CaHASE), U. K. C. A. H. A. S. E. (2013) · Clinical Endocrinology · doi:10.1111/cen.12045 · Cited by 70
Self-citationCullins in Human Intra-Uterine Growth Restriction: Expressional and Epigenetic Alterations
Gascoin-Lachambre, G., Buffat, C., Rebourcet, R., Chelbi, S. T., Rigourd, V., Mondon, F., Mignot, T.-M., Legras, E., Siméoni, U., Vaiman, D., et al. (2009) · Placenta · doi:10.1016/j.placenta.2009.11.008 · Cited by 69 · cited 1×
“epigenetic mechanism.(32) There is scattered evidence for other exposures during pregnancy or early infancy, for example maternal smoking.”
BackgroundDidangelos, T., Thanopoulou, A. C., Bousboulas, S., Sambanis, C., Athyros, V. G., Spanou, E., Dimitriou, K., Pappas, S. I., Karamanos, B. G., & Karamitsos, D. T. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125004466 · Cited by 69 · cited 2×
“A study by Didangelos et al.(75) has shown that although the addition of orlistat to moderate calorie restriction (1300kg/day) further reduced body weight by only another 1.”
MethodInfluentialLong-Term Effects of Low-Calorie Diet on the Metabolic Syndrome in Obese Nondiabetic Patients
Muzio, F., Mondazzi, L., Sommariva, D., & Branchi, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1485 · Cited by 64
Han, T. S., Hart, C., Haig, C. E., Logue, J., Upton, M. N., Watt, G. C. M., & Lean, M. E. J. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007682 · Cited by 50 · cited 1×
“There is scattered evidence for other exposures during pregnancy or early infancy, for example maternal smoking.(33) Aside from certain drug effects (e.”
BackgroundSelf-citationPatients with insulinoma show insulin resistance in the absence of arterial hypertension
Pontiroli, A. E., Alberetto, M., & Pozza, G. (1992) · Diabetologia · doi:10.1007/bf00400934 · Cited by 48 · cited 1×
“However, this association is probably not causally linked since controlling hypertension neither improves glucose intolerance or hyperinsulinaemia(38) and hypertension is not observed in patients with insulinoma.(39) On the other hand, obesity contributes to hypertension and hyperinsulinaemia, while weight reduction u…”
BackgroundLeptin therapy for partial lipodystrophy linked to a PPAR‐γ mutation
Guettier, J., Park, J. Y., Cochran, E. K., Poitou, C., Basdevant, A., Meier, M., Clément, K., Magré, J., & Görden, P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03095.x · Cited by 47
Gene variants, insulin resistance, and dyslipidaemia
Laakso, M. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200404000-00004 · Cited by 43
Algindan, Y., Hankey, C., Govan, L., Gallagher, D., Heymsfield, S. B., & Lean, M. E. J. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515003670 · Cited by 40 · cited 1×
“A more rational approach to obesity would use the published, validated, equations to estimate body fat from a combination of anthropometric measurements.(17) Similar equations are available to estimate skeletal muscle mass, which is fundamental to metabolic risk status.”
MethodSelf-citationLawlor, D. A., Lean, M. E. J., & Sattar, N. A. (2006) · BMJ · doi:10.1136/bmj.333.7577.1060 · Cited by 32
Self-citationBody mass index and obesity among adults in Finland
Lahti‐Koski, M. (2001) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 29
Walker, U. A., Kirschfink, M., & Peter, H. H. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg076 · Cited by 16 · cited 1×
“By contrast, individuals with acquired partial lipodystrophy (as the result of persistent complement activation) have intact PPARg and treatment with the PPARg agonist rosiglitazone increases subcutaneous adipose tissue through adipocyte proliferation.(48) In patients with spinal cord injury, extreme disuse and conseq…”
BackgroundKuesters, S., Grueneberger, J. M., Baumann, T., Bukhari, W., Daoud, M., Hopt, U. T., & Karcz, W. K. (2011) · Surgical Endoscopy · doi:10.1007/s00464-011-2098-y · Cited by 14 · cited 1×
“The greater, more rapid weight losses by surgery are off-set by a number of permanently social and health consequences that the individual has to adapt, including interference with daily activities such as the impossibility of eating normal family meals and the hazards of dumping syndrome, and of micronutrient deficie…”
BackgroundLow Fat vs. Low Carbohydrate Diet Strategies for Weight Reduction: A Meta-Analysis
Boaz, M., & Raz, O. (2015) · Journal of Obesity & Weight loss Therapy · doi:10.4172/2165-7904.1000273 · Cited by 12 · cited 1×
“Similar findings were observed in another meta-analysis of nine studies (n1⁄4 1161) in those who were exposed to either low-carbohydrate or low-fat diets.(71) Physical activity has benefits above its role in weight control by reducing the risk of developing metabolic syndrome.”
ResultGreenfield, D., Blewitt, A., Coleman, R. E., Walsh, J., Snowden, J. A., Ross, R. J. M., & Han, T. S. (2015) · Clinical Endocrinology · doi:10.1111/cen.12869 · Cited by 5
Self-citationMetabolic Syndrome Sinkholes: What to Do When Occam's Razor Gets Blunted
Feldman, R. D., Anderson, T. J., & Touyz, R. M. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.12.035 · Cited by 3 · cited 1×
“Some experts have been critical of the concept of the metabolic syndrome, referring to the dominant role waist circumference over the remaining components of the syndrome such that, in its entirety, the metabolic syndrome appears to add little improvement on waist circumference alone on risk assessment or therapeutic…”
BackgroundEvolution of the human life cycle
Bogin, B., & Smith, B. H. (1996) · American Journal of Human Biology · doi:10.1002/(sici)1520-6300(1996)8:6
Research works printed but not linked: 6
- Bouchard C, 1995, Int J Obes, 19, S52
- Han TS, 1995, Proc Nutr Soc, 54, 182A
- Kelly IE, 2001, Diabetes Care, 24, 683, 10.2337/diacare.24.4.683 · DOI · Paper page
- 10.1001/archinte.1989.00390070054005 · DOI · Paper page
- Greenfield DM, 2015, Clin Endocrinol (Oxf)
- Department of Health. Alcohol Guidelines Review – Report from the Guidelines development group to the UK Chief Medical Officers, January 2016. Produced by William Lea for the Department of Health.
Cited by
Mechanisms of Oxidative Stress in Metabolic Syndrome
Masenga, S. K., Kabwe, L. S., Chakulya, M., & Kirabo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097898 · Cited by 717
“Metabolic syndrome is characterized by obesityrelated problems, indicating a relationship between obesity and metabolic syndrome [10].”
BackgroundCardiovascular risk in diabetes mellitus: Epidemiology, assessment and prevention
Wong, N. D., & Sattar, N. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00877-z · Cited by 495
Muzurović, E., Mikhailidis, D. P., & Mantzoros, C. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154770 · Cited by 336
Blood metabolome predicts gut microbiome α-diversity in humans
Wilmanski, T., Rappaport, N., Earls, J. C., Magis, A. T., Manor, O., Lovejoy, J., Omenn, G. S., Hood, L., Gibbons, S. M., & Price, N. D. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0233-9 · Cited by 328
Neuro-toxic and Reproductive Effects of BPA
Santoro, A., Chianese, R., Troisi, J., Richards, S., Nori, S. L., Fasano, S., Guida, M., Plunk, E., Viggiano, A., Pierantoni, R., et al. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190726112101 · Cited by 278
Metadata
- Authors
- Han, T. S., & Lean, M. E.
- Affiliations
- Royal Holloway University of London (GB)
- Human Nutrition, School of Medicine, University of Glasgow, UK
- Corresponding author
- Han, Thang S
- ORCID
- Han, Thang S
- Venue
- JRSM Cardiovascular Disease
- Publisher
- SAGE Publications
- Published
- 2016-01-01
- Volume
- 5
- Pages
- 2048004016633371-2048004016633371
- ISSN
- 2048-0040 (ISSN-L)
- PMC
- PMC4780070
- OpenAlex
- W2311898277
- Cited by
- 500
- References
- 102
- Citations by year
- 2026: 15 · 2025: 38 · 2024: 51 · 2023: 46 · 2022: 55 · 2021: 67 · 2020: 71 · 2019: 50 · 2018: 52 · 2017: 43 · 2016: 10
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- JRSM Cardiovascular Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- metabolic syndrome, obesity, cardiovascular disease, type 2 diabetes, waist circumference, intra-abdominal fat, ectopic fat, weight management, anti-obesity drugs, bariatric surgery, insulin resistance, antidiabetic drugs, smoking, subcutaneous adipose tissue, skeletal muscle mass, antiretroviral drugs, fetal growth restriction, diet and exercise
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.